LMND vs. EVER: Which InsurTech Stock Is the Better Pick?

Impact · against what's priced in

Lemonade shows positive momentum through diversification and projected growth, while both companies face systemic pressures from inflation and digitizing legacy competitors. The guidance for Lemonade provides a concrete valuation floor, whereas EverQuote remains exposed to sector-wide headwinds without specific offsets.

LMND+0.30

No priced-in read yet

In context

The company's projected 2025 revenues of $727-$732 million and expected 30% IFP growth for 2026 provide concrete benchmarks for scalability.

Read from the article alone

• regulation▲63%
• ai
• inflation
• EVER
• LMND
• insurance
• insurtech
• profitability
• regtech
• telematics